skip to main content
Tipo de recurso Mostra resultados com: Mostra resultados com: Índice

PRETREATMENT OF CRUDE PANCREATIC ISLETS WITH MITOMYCIN C PROLONGS GRAFT SURVIVAL TIME IN XENOGENEIC RAT-TO-MOUSE MODEL1

Grochowiecki, Tadeusz ; Gotoh, Mitsukazu ; Dono, Keizo ; Takeda, Yutaka ; Nishihara, Masayoshi ; Ohta, Yoshihiko ; Ota, Hirofumi ; Ohzato, Hiroki ; Okuyama, Masaki ; Shimizu, Junzo ; Kimura, Fumihiko ; He, Li ; Nagano, Hiroaki ; Nakamori, Shoji ; Umeshita, Koji ; Sakon, Masato ; Monden, Morito

Transplantation, 1999, Vol.67(11), pp.1474-1477 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
  • Título:
    PRETREATMENT OF CRUDE PANCREATIC ISLETS WITH MITOMYCIN C PROLONGS GRAFT SURVIVAL TIME IN XENOGENEIC RAT-TO-MOUSE MODEL1
  • Autor: Grochowiecki, Tadeusz ; Gotoh, Mitsukazu ; Dono, Keizo ; Takeda, Yutaka ; Nishihara, Masayoshi ; Ohta, Yoshihiko ; Ota, Hirofumi ; Ohzato, Hiroki ; Okuyama, Masaki ; Shimizu, Junzo ; Kimura, Fumihiko ; He, Li ; Nagano, Hiroaki ; Nakamori, Shoji ; Umeshita, Koji ; Sakon, Masato ; Monden, Morito
  • É parte de: Transplantation, 1999, Vol.67(11), pp.1474-1477
  • Descrição: BACKGROUND.: Rejection of pancreatic islet grafts is still a serious problem. We evaluated the effect of mitomycin C (MMC) on the survival of crude islets grafts after xenogeneic islet transplantation. METHODS.: WS (RT1k) rat islets pretreated with various concentrations of MMC (0, 1, 3.2, 10, 32, 50, 100, 320, and 1,000 μg/ml) were transplanted into C57BL/6 mice with streptozotocin-induced diabetes. In vivo graft function was assessed by a daily measurement of nonfasting blood glucose concentration in each animal. We also examined the separate effect of MMC on purified islets and contaminants present in the crude islet preparation. RESULTS.: MMC at doses of 10, 32, 50, and 100 μg/ml resulted in a significant prolongation of the mean graft survival time from a control of 12.4±2.5 days to 23±7.4, 17.5±5.4, 25.5±14.7, and 26.7±8.9 days, respectively. Deterioration of glucose metabolism was noted when the dose exceeded 32 μg/ml, whereas at 320 μg/ml, MMC failed to restore normoglycemia. Prolongation of survival time of crude islets was the result of its effect on islets and contaminant components of the crude islet preparation. In vitro study showed that MMC treatment at a higher concentration than 10 μg/ml reduces the stimulatory as well as proliferative capacity of lymph node cells. CONCLUSIONS.: Pretreatment of pancreatic islets with MMC at 10 μg/ml prolongs xenograft survival without deterioration of in vivo graft function. This novel treatment modality represents a new strategy for the modulation of immunity of islets and contaminants in crude islet preparations.

Buscando em bases de dados remotas. Favor aguardar.